Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Alcohol as a Modifiable Risk Factor for Atrial Fibrillation [NA]

View source ↗

Summary

A Danish clinical trial is examining alcohol as a modifiable risk factor for atrial fibrillation. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Atrial Fibrillation (AF) | NA | Status: NOT_YET_RECRUITING